ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results ELEMENT--Back to the NewsroomClearPoint Neuro Reports Fourth Quarter and Full Year 2025 ResultsRecord Revenue and IRRAS Holdings Acquisition Highlight the Company's 'Fast. Forward.' StrategySOLANA BEACH, CA / ACCESS Newswire/ March 17, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for i ...